Franklin Resources
BCAX

Franklin Resources’s Bicara Therapeutics BCAX Stock Holding History

Franklin Resources’s Portfolio BCAX Stock Details BCAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$58M Buy
1,951,892
+330,249
+20% +$7.37M 0.01% 625
2026
Q1 		$32.3M Buy
1,621,643
+1,618
+0.1% +$27.9K 0.01% 791
2025
Q4 		$27.3M Buy
+1,620,025
New +$27.7M 0.01% 853
2025
Q2 		– Sell
-13,669
Closed -$178K – 3154
2025
Q1 		$178K Buy
+13,669
New +$182K ﹤0.01% 2720

Other funds holding BCAX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
RTM
Red Tree Management Redwood City, California $147M AUM 202.18% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Franklin Resources's BCAX Position: Q2 2026 in Review

Franklin Resources increased its Bicara Therapeutics (BCAX) stake by 20% in Q2 2026, buying an estimated $7.37M and bringing the position to 1,951,892 shares worth $58M. The position accounts for 0.01% of the portfolio, ranked #625.

Franklin Resources first reported a position in BCAX in Q1 2025 and has held it in 4 quarters since. 172 funds tracked by Wall St. Rank hold BCAX as of Q2 2026.

  • Franklin Resources held 1,951,892 shares of Bicara Therapeutics worth $58M as of Q2 2026.
  • Franklin Resources bought 330,249 Bicara Therapeutics shares in Q2 2026, an estimated $7.37M.
  • Bicara Therapeutics made up 0.01% of Franklin Resources's portfolio in Q2 2026, its #625 holding.
  • Franklin Resources first reported a position in Bicara Therapeutics in Q1 2025 and has held it in 4 quarters since.
  • 172 funds tracked by Wall St. Rank held Bicara Therapeutics as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.